The effect of smoking status on survival following radiation therapy for non-small cell lung cancer

Lung Cancer

Volumn 44, Issue 3, 2004, Pages 287-293

  Fox, Jana L ^a   Rosenzweig, Kenneth E ^a   Ostroff, Jamie S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Non small cell lung cancer; Radiation therapy; Radiotherapy; Smoking; Survival; Tobacco

Indexed keywords

PLATINUM DERIVATIVE;

ADULT; AGED; ARTICLE; CALCULATION; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CIGARETTE SMOKING; CONSULTATION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SMOKING; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 2342620690     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2003.11.012     Document Type: Article

References (37)

1. Dresler C.M. Is it more important to quit smoking than which chemotherapy is used? Lung Cancer. 39:2003;119-124
2. Dresler C.M., Gritz E.R. Smoking, smoking cessation and the oncologist. Lung Cancer. 34:2001;315-323
3. Yu G.P., Ostroff J.S., Zhang Z.F., Tang J., Schantz S.P. Smoking history and cancer patient survival: a hospital cancer registry study. Cancer Detect. Prev. 21:1997;497-509
4. Fleshner N., Garland J., Moadel A., Herr H., Ostroff J., Trambert R., et al. Influence of smoking status on the disease-related outcomes of patients with tobacco-associated superficial transitional cell carcinoma of the bladder. Cancer. 86:1999;2337-2345
5. Kim DH, Ostroff JS, Berwick M, Katz J, Simmons R, Russo P. Influence of smoking history on the disease-related outcomes of patients with renal cell carcinoma, under review.
6. Richardson G.E., Tucker M.A., Venzon D.J., Linnoila R.I., Phelps R., Phares J.C., et al. Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers. Ann. Intern. Med. 119:1993;383-390
7. Myrdal G., Gustafsson G., Lambe M., Horte L.G., Stahle E. Outcome after lung cancer surgery. Factors predicting early mortality and major morbidity. Eur. J. Cardiothorac. Surg. 20:2001;694-699
8. McCulloch T.M., Jensen N.F., Girod D.A., Tsue T.T., Weymuller E.A. Jr. Risk factors for pulmonary complications in the postoperative head and neck surgery patient. Head Neck. 19:1997;372-377
9. Myrdal G., Lambe M., Gustafsson G., Nilsson K., Stahle E. Survival in primary lung cancer potentially cured by operation: influence of tumor stage and clinical characteristics. Ann. Thorac. Surg. 75:2003;356-363
10. Fujisawa T., Iizasa T., Saitoh Y., Sekine Y., Motohashi S., Yasukawa T. Smoking before surgery predicts poor long-term survival in patients with stage I non-small-cell lung carcinomas. J. Clin. Oncol. 17:1999;2086-2091
11. Johnston-Early A., Cohen M.H., Minna J.D., Paxton L.M., Fossieck B.E. Jr., Ihde D.C., et al. Smoking abstinence and small cell lung cancer survival. An association. Jama. 244:1980;2175-2179
12. Bergman B., Sorenson S. Smoking and effect of chemotherapy in small cell lung cancer. Eur. Respir. J. 1:1988;932-937
13. Videtic G.M., Stitt L.W., Dar A.R., Kocha W.I., Walter I., Tomiak A.T., et al. Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival. J. Clin. Oncol. 21:2003;1544-1549
14. Wong NS, Lim ST, Lim W-T, Leong S-S, Tan E-H. ZD1839 is more effective in patients with non-small cell lung cancer who were lifetime non-tobacco users (Abstract). The American Society of Clinical Oncology Meeting Proceedings, 39th Annual Meeting 2003;22:694.
15. Shah NT, Miller VA, Kris MG, Patel J, Venkatraman E, Benporat L. Bronchioalveolar histology and smoking history predict response to gefitinib (Abstract). The American Society of Clinical Oncology Meeting Proceedings, 39th Annual Meeting 2003;22:628.
16. Browman G.P., Wong G., Hodson I., Sathya J., Russell R., McAlpine L., et al. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N. Engl. J. Med. 328:1993;159-163
17. Browman G.P., Mohide E.A., Willan A., Hodson I., Wong G., Grimard L., et al. Association between smoking during radiotherapy and prognosis in head and neck cancer: a follow-up study. Head Neck. 24:2002;1031-1037
18. Eifel P.J., Jhingran A., Bodurka D.C., Levenback C., Thames H. Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer. J. Clin. Oncol. 20:2002;3651-3657
19. Monson J.M., Stark P., Reilly J.J., Sugarbaker D.J., Strauss G.M., Swanson S.J., et al. Clinical radiation pneumonitis and radiographic changes after thoracic radiation therapy for lung carcinoma. Cancer. 82:1998;842-850
20. Burns D.M. Primary prevention, smoking, and smoking cessation: implications for future trends in lung cancer prevention. Cancer. 89:2000;2506-2509
21. The Surgeon General's 1990 Report on the Health Benefits of Smoking Cessation Executive Summary - Introduction, Overview, and Conclusions. Morbidity and Mortality Weekly Report, Centers for Disease Control and Prevention 1990;39:2-10.
22. Ostroff J.S., Jacobsen P.B., Moadel A.B., Spiro R.H., Shah J.P., Strong E.W., et al. Prevalence and predictors of continued tobacco use after treatment of patients with head and neck cancer. Cancer. 75:1995;569-576
23. Cox J.D., Stetz J., Pajak T.F. Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC). Int. J. Radiat. Oncol. Biol. Phys. 31:1995;1341-1346
24. Kaplan E., Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:1958;457
25. Cox DR. Regression models and life-tables, J Roy Stat Soc, Ser B 1972;34:187-220.
26. Mountain C.F. Revisions in the International System for Staging Lung Cancer. Chest. 111:1997;1710-1717
27. Janssen-Heijnen M.L., Schipper R.M., Razenberg P.P., Crommelin M.A., Coeberg J.W. Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based study. Lung Cancer. 21:1998;105-113
28. Tammemagi C.M., Neslund-Dudas C., Simoff M., Kvale P. Impact of comorbidity on lung cancer survival. Int. J. Cancer. 103(6):2003;792-802
29. Gritz E.R., Carr C.R., Rapkin D., Abenayor E., Chang L.J., Wong W.K., et al. Predictors of long-term smoking cessation in head and neck cancer patients. Cancer Epidemiol. Biomarkers Prev. 2(3):1993;261-270
30. Vander Ark W., DiNardo L.J., Oliver D.S. Factors affecting smoking cessation in patients with head and neck cancer. Laryngoscope. 107:1997;888-892
31. Silverman S. Jr., Gorsky M, Greenspan D. Tobacco usage in patients with head and neck carcinomas: a follow-up study on habit changes and second primary oral/oropharyngeal cancers. J. Am. Dent. Assoc. 106:1983;33-35
32. Gritz E.R., Nisenbaum R., Elashoff R.E., Holmes E.C. Smoking behavior following diagnosis in patients with stage I non-small cell lung cancer. Cancer Causes Control. 2:1991;105-112
33. Sanderson Cox L., Sloan J.A., Patten C.A., Bonner J.A., Geyer S.M., McGinnis W.L., et al. Smoking behavior of 226 patients with diagnosis of stage IIIA/IIIB non-small cell lung cancer. Psychooncology. 11:2002;472-478
34. Cox L.S., Africano N.L., Tercyak K.P., Taylor K.L. Nicotine dependence treatment for patients with cancer. Cancer. 98:2003;632-644
35. McBride C.M., Ostroff J.S. Teachable moments for promoting smoking cessation: the context of cancer care and survivorship. Cancer Control. 10:2003;325-333
36. Gandara D.R., Chansky K., Albain K.S., Leigh B.R., Gaspar L.E., Lara P.N. Jr., et al. Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer: phase II Southwest Oncology Group Study S9504. J. Clin. Oncol. 21:2003;2004-2010
37. Curran WJSC, Langer CJ. Long-term benefit is observed in a phase III comparison of sequential vs. concurrent chemo-radiation for patients with unresected stage III NSCLC: RTOG 9410 (Abstract). American Society of Clinical Oncology Meeting Proceedings, 39th Annual Meeting 2003;22:621.